BTN2A2

Li Xiao1, Rong Hu2, Wei Chen3

  • 1National Joint Local Engineering Laboratory for Cell Engineering and Biomedicine Technique, 6 Ankang Avenue, Guian New District, Guizhou, China, 561113; Department of Histology and Embryology, Guizhou Medical University, 6 Ankang Avenue, Guian New District, Guizhou, China, 561113; Key Laboratory for Research on Autoimmune Diseases of Higher Education schools in Guizhou Province, 6 Ankang Avenue, Guian New District, Guizhou, China, 561113.

Neoplasia (New York, N.Y.)
|April 22, 2025
PubMed
概括

一种针对BTN2A2免疫检查点的新疗法有效地减少了胰腺癌和质瘤模型中的瘤大小. 这种新型免疫检查点抑制剂 (ICI) 增强了抗瘤免疫细胞的活性,并使瘤微环境正常化.